Skip to main content

Pairings: Sep 8, 2010


XDx announced the appointment of Matthew Meyer as its VP of corporate development and legal affairs.

Prior to XDx, Meyer was VP of business development and general counsel at Cerimon Pharmaceuticals. Meyer also previously held senior management positions at Draeger Medical Systems and at Novartis Pharma .

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.